China-based ShangPharma has named Mitchell Reff as the company’s chief biologics officer.
Leading Chinese R&D outsourcing firm ShangPharma Corp (NYSE: SHP) says that it has reached the first…
Asia-PacificEli LillyJiangsu Hengrui MedicinePharmaceuticalResearchShangPharma
Our latest news direct to your inbox
Back to top